SBBP News and Press, Strongbridge Biopharma plc From 07/13/21

~ Study Confirms Long-Term Treatment with KEVEYIS is Safe and Effective for Chronic Use ~ ~ Analyses Provide Potentially Useful Information to Help Guide Clinician Patient Counseling & Management When Starting Treatment with KEVEYIS ~ DUBLIN, Ireland and TREVOSE, Pa., ...

Over 70 multi-billion dollar deals announced in the first half of the year. SPAC IPOs pick up pace and Chamath Palihapitiya files four new biotech focused SPACs. Icon completes the acquisition of PRA Health Sciences. For further details see: Merger Arbitrage Mondays - MK...

Xeris announced last month that it would be acquiring Strongbridge Biopharma in an all-stock and CVR deal. Xeris has been a holding of mine for a while, and now the company has added further depth to its pipeline with another endocrinology product, Recorlev. I view the long-term o...

7 new deals and 7 SPAC business combinations announced last week. Lydall stock jumps 85% after news of acquisition. Buzzfeed to go public in a SPAC deal. For further details see: Merger Arbitrage Mondays - Buzzfeed To Go Public With 890 Fifth Avenue Partners

CAI International and Mitsubishi HC Capital join forces. At Home Group receives an improved offer but its largest shareholder is not happy with the higher offer. Multiple active deals receive required regulatory and shareholder approvals. For further details see: Merger ...

Nearly $13 billion worth of all cash deals announced last week. Magnachip receives a higher bid, but trades well below the original acquisition price due to regulatory risks. SPAC activity picks up with 9 new IPOs filed. For further details see: Merger Arbitrage Mondays ...

Regional bank consolidation continues with three new bank deals announced last week. Extended Stay America catches a higher bid. Chamath Palihapitiya files for four new biotech-focused SPACs. For further details see: Merger Arbitrage Mondays: Extended Stay America Receiv...

Strongbridge Biopharma (SBBP) announces that the United States Patent and Trademark Office ((USPTO)) has issued U.S. Patent No. 11,020,393 covering a method of treating certain Cushing’s syndrome patients with RECORLEV (levoketoconazole).The term of the U.S. pa...

DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced t...

Ali Group ignites a potential bidding war for Welbilt (WBT). Cimarex Energy (XEC) and Cabot Oil & Gas Corporation (COG) combine in an $8.5 billion all-stock deal. United Rentals (UFN) completes the acquisition of General Finance Corporation (GFN) in 40 days. For further ...